Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data.
BACKGROUND: Access to unpublished clinical study reports (CSRs) is currently being discussed as a means to allow unbiased evaluation of clinical research. The Institute for Quality and Efficiency in Health Care (IQWiG) routinely requests CSRs from manufacturers for its drug assessments. Our objectiv...
Main Authors: | Beate Wieseler, Natalia Wolfram, Natalie McGauran, Michaela F Kerekes, Volker Vervölgyi, Petra Kohlepp, Marloes Kamphuis, Ulrich Grouven |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-10-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3793003?pdf=render |
Similar Items
-
Impact of inclusion of industry trial results registries as an information source for systematic reviews.
by: Regine Potthast, et al.
Published: (2014-01-01) -
Access to regulatory data from the European Medicines Agency: the times they are a-changing
by: Wieseler Beate, et al.
Published: (2012-10-01) -
Reporting bias in medical research - a narrative review
by: Kölsch Heike, et al.
Published: (2010-04-01) -
Negative pressure wound therapy: Potential publication bias caused by lack of access to unpublished study results data
by: Sauerland Stefan, et al.
Published: (2008-02-01) -
A study of returnees for psychotherapy to the Boston Veterans Administration Mental Hygiene Clinic
by: McGauran, Madeleine R
Published: (2016)